Skip to content

Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy

Evaluation of Pars Plana Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04278079
Enrollment
52
Registered
2020-02-20
Start date
2015-01-31
Completion date
2020-02-29
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Internal Limiting Membrane Peeling, Myopic Traction Maculopathy, Pars Plana Vitrectomy

Brief summary

Investigate the effectiveness and safety of pars plans vitrectomy, with internal limiting membrane peeling for cases of myopic traction maculopathy

Detailed description

Performing pars plana vitrectomy for highly myopic patients with decreased visual acuity is the standard of care for patients with myopic traction. A variety of findings are seen by Optical Coherence Tomography. Epiretinal membranes, retinoschisis, lamellar macular holes, and full thickness macular holes are seen. Undergoing vitrectomy, with or without tamponade, in our center, is retrospectively evaluated. Visual acuity change, as well as improvement of the retinal structure by OCT will be examined.

Interventions

PROCEDUREPars Plana Vitrectomy with Internal Limiting Membrane peel

Pars plana vitrectomy with staining and peeling of internal limiting membrane

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Highly myopic patients, having a refractive errors (spherical equivalent) of more than - 8 Diopter, or an axial length more than 26.5 mm. * Best Corrected Visual Acuity less than 0.1 * Spectral Domain Optical Coherence Tomography showed; staphylomatous changes, with either: Macular retinoschisis, foveal retinal detachment, full thickness macular hole (with or without macualr hole retinal detachment), or lamellar macular hole, with epiretinal membrane At least 6 months follow-up

Exclusion criteria

* Eyes with diffuse chorioretinal macular atrophy * Concomitant presence of a choroidal neovascular membrane * Young patients less than 21 years old. * History of trauma * Dense media opacity (corneal/ lenticular)

Design outcomes

Primary

MeasureTime frame
Improvement of best corrected visual acuity6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026